Schedule 13D ownership disclosure

CHINOOK THERAPEUTICS INC

Security class unavailable · CUSIP: 16961L106

Event date: 2023-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-120754
Form type
SC 13D/A
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Nov 22, 2023
Reporting period
Aug 11, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub